Review




Structured Review

Caris Life Sciences routine molecular profiling
Routine Molecular Profiling, supplied by Caris Life Sciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/routine+molecular+profiling/pm42113041-45-3-7?v=Caris+Life+Sciences
Average 86 stars, based on 1 article reviews
routine molecular profiling - by Bioz Stars, 2026-06
86/100 stars

Images



Similar Products

86
Caris Life Sciences routine molecular profiling
Routine Molecular Profiling, supplied by Caris Life Sciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/routine+molecular+profiling/pm42113041-45-3-7?v=Caris+Life+Sciences
Average 86 stars, based on 1 article reviews
routine molecular profiling - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Caris Life Sciences routine comprehensive tumor molecular profiling
<t>Molecular</t> features of colorectal <t>cancer</t> ( A ) and endometrial cancer ( B ). The mutational landscape and patient demographic/clinical characteristics (PD-L1 by IHC, MSI <t>comprehensive,</t> age, and sex) of the four cohorts for each cancer type were plotted using the GenVisR package of R.
Routine Comprehensive Tumor Molecular Profiling, supplied by Caris Life Sciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/routine+molecular+profiling/pmc10812383-47-39-31?v=Caris+Life+Sciences
Average 86 stars, based on 1 article reviews
routine comprehensive tumor molecular profiling - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

Image Search Results


Molecular features of colorectal cancer ( A ) and endometrial cancer ( B ). The mutational landscape and patient demographic/clinical characteristics (PD-L1 by IHC, MSI comprehensive, age, and sex) of the four cohorts for each cancer type were plotted using the GenVisR package of R.

Journal: Cancer Research Communications

Article Title: Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity

doi: 10.1158/2767-9764.CRC-23-0312

Figure Lengend Snippet: Molecular features of colorectal cancer ( A ) and endometrial cancer ( B ). The mutational landscape and patient demographic/clinical characteristics (PD-L1 by IHC, MSI comprehensive, age, and sex) of the four cohorts for each cancer type were plotted using the GenVisR package of R.

Article Snippet: We conducted a retrospective analysis on the genomic profiles of 1,870 patients with colorectal cancer, 4,481 patients with endometrial cancer, and 8,190 patients with ovarian cancer that underwent genomic profiling by Caris Life Sciences (CLS) as part of their routine comprehensive tumor molecular profiling.

Techniques: